Pathogen or autoantibody (targeted via antibody-mediated neutralization or modulation) (None established; context-dependent)

The term "Pathogens/autoantibodies via antibody-mediated neutralization/modulation" refers broadly to any **pathogenic organism**, such as viruses or bacteria, and **disease-causing autoantibodies**, that are therapeutically targeted through the action of antibodies. In this context, **neutralizing antibodies bind directly to surface structures on pathogens**, preventing their entry into host cells and thereby blocking infection[1][2]. Similarly, some therapies aim at modulating harmful autoimmune responses by targeting pathogenic autoantibodies themselves[3]. This is not one discrete molecular entity but encompasses many possible targets depending on the disease—each with its own structure and function. Because this entry does not specify an individual protein/receptor/enzyme/transporter/etc., it cannot be mapped directly onto standard molecular target classifications used in pharmacology. Instead, it describes an important class of therapeutic mechanisms—namely those involving direct interaction between therapeutic antibodies and their respective antigens found either on infectious agents or within dysregulated components of the immune system itself.

Other names

Pathogen (general)AutoantibodyAntigen targeted by antibody-mediated neutralizationAntigen targeted by antibody modulation

Antibody-mediated neutralization: Direct binding to pathogen surface proteins to block infection[1][2]. Antibody-mediated modulation: Binding to autoantibodies/autoantigens to alter immune responses[3].